Stage IV Ovarian Cancer Withdrawn Phase Trials for Cyclophosphamide (DB00531)

IndicationStatusPhase
DBCOND0030167 (Stage IV Ovarian Cancer)WithdrawnNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00551265Oregovomab With or Without Cyclophosphamide in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer That Responded to Second-Line ChemotherapyTreatment